miR-322 regulates insulin signaling pathway and protects against metabolic syndrome-induced cardiac dysfunction in mice

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1862, Issue 4, 2016, Pages 611-621

  Marchand, Alexandre ^a   Atassi, Fabrice ^a,b,c   Mougenot, Nathalie ^c   Clergue, Michel ^a,b,c   Codoni, Veronica ^a,b,c   Berthuin, Jeremy ^a,b,c   Proust, Carole ^a,b,c   Trégouët, David Alexandre ^a,b,c   Hulot, Jean Sébastien ^a,b,c   Lompré, Anne Marie ^a,b,c  

^a ICAN Institute for Cardiometabolism and Nutrition   (France)

^b Institute OfCardiometabolism and Nutrition   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

Cardiomyopathy; High fat diet; Insulin pathway; Metabolic syndrome; MicroRNA

Indexed keywords

CARDIOPROTECTIVE AGENT; CYCLIN D1; GLUCOSE; INSULIN GROWTH FACTOR 1 RECEPTOR; INSULIN RECEPTOR; MESSENGER RNA; MICRORNA; MICRORNA 322; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PROTECTIVE AGENT; PROTEIN KINASE B; RENILLA LUCIFERIN 2 MONOOXYGENASE; SIRTUIN 4; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE LENGTH; CARDIOMYOPATHY; CELL FUNCTION; CONTROLLED STUDY; DISEASE COURSE; DRUG BINDING SITE; DRUG BIOAVAILABILITY; DRUG POTENCY; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FOLLOW UP; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORT; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART PROTECTION; HEART VENTRICLE SIZE; HEART WEIGHT; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; LIPID DIET; MALE; METABOLIC REGULATION; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; TREATMENT DURATION; UPREGULATION; VASCULAR SMOOTH MUSCLE CELL;

EID: 84958259411     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2016.01.010     Document Type: Article

References (28)

1. Ardern C.I., Janssen I. Metabolic syndrome and its association with morbidity and mortality. Appl. Physiol. Nutr. Metab. 2007, 32(1):33-45. Feb.
2. Park S.Y., Cho Y.R., Kim H.J., Higashimori T., Danton C., Lee M.K., Dey A., Rothermel B., Kim Y.B., Kalinowski A., Russell K.S., Kim J.K. Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice. Diabetes 2005, 54:3530-3540.
3. Gray S., Kim J.K. New insights into insulin resistance in the diabetic heart. Trends Endocrinol. Metab. 2011, 22:394-403.
4. Dumortier O., Hinault C., Van Obberghen E. MicroRNAs and metabolism crosstalk in energy homeostasis. Cell Metab. 2013, 18:312-324.
5. Frost R.J., Olson E.N. Control of glucose homeostasis and insulin sensitivity by the Let-family of microRNAs. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:21075-21080.
6. Jordan S.D., Kruger M., Willmes D.M., Redemann N., Wunderlich F.T., Bronneke H.S., Merkwirth C., Kashkar H., Olkkonen V.M., Bottger T., Braun T., Seibler J., Bruning J.C. Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat. Cell Biol. 2011, 13:434-446.
7. Trajkovski M., Hausser J., Soutschek J., Bhat B., Akin A., Zavolan M., Heim M.H., Stoffel M. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 2011, 474:649-653.
8. Kornfeld J.W., Baitzel C., Konner A.C., Nicholls H.T., Vogt M.C., Herrmanns K., Scheja L., Haumaitre C., Wolf A.M., Knippschild U., Seibler J., Cereghini S., Heeren J., Stoffel M., Bruning J.C. Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b. Nature 2013, 494:111-115.
9. Lu H., Buchan R.J., Cook S.A. MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism. Cardiovasc. Res. 2010, 86:410-420.
10. Grueter C.E., van Rooij E., Johnson B.A., DeLeon S.M., Sutherland L.B., Qi X., Gautron L., Elmquist J.K., Bassel-Duby R., Olson E.N. A cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell 2012, 149:671-683.
11. Gamez B., Rodriguez-Carballo E., Bartrons R., Rosa J.L., Ventura F. MicroRNA-322 (miR-322) and its target protein Tob2 modulate Osterix (Osx) mRNA stability. J. Biol. Chem. 2013, 288:14264-14275.
12. Rosa A., Ballarino M., Sorrentino A., Sthandier O., De Angelis F.G., Marchioni M., Masella B., Guarini A., Fatica A., Peschle C., Bozzoni I. The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:19849-19854.
13. Sarkar S., Dey B.K., Dutta A. MiR-322/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A. Mol. Biol. Cell 2010, 21:2138-2149.
14. Merlet E., Atassi F., Motiani R.K., Mougenot N., Jacquet A., Nadaud S., Capiod T., Trebak M., Lompre A.M., Marchand A. miR-424/322 regulates vascular smooth muscle cell phenotype and neointimal formation in the rat. Cardiovasc. Res. 2013, 98:458-468.
15. Smyth G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004, 3. (Article3).
16. Araki H., Knapp C., Tsai P., Print C. GeneSetDB: a comprehensive meta-database, statistical and visualisation framework for gene set analysis. FEBS Open Biol. 2012, 2:76-82.
17. Nasrin N., Wu X., Fortier E., Feng Y., Bare O.C., Chen S., Ren X., Wu Z., Streeper R.S., Bordone L. SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells. J. Biol. Chem. 2010, 285:31995-32002.
18. Haigis M.C., Mostoslavsky R., Haigis K.M., Fahie K., Christodoulou D.C., Murphy A.J., Valenzuela D.M., Yancopoulos G.D., Karow M., Blander G., Wolberger C., Prolla T.A., Weindruch R., Alt F.W., Guarente L. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 2006, 126:941-954.
19. Calligaris S.D., Lecanda M., Solis F., Ezquer M., Gutierrez J., Brandan E., Leiva A., Sobrevia L., Conget P. Mice long-term high-fat diet feeding recapitulates human cardiovascular alterations: an animal model to study the early phases of diabetic cardiomyopathy. PLoS ONE 2013, 8:e60931.
20. Hulot J.S., Fauconnier J., Ramanujam D., Chaanine A., Aubart F., Sassi Y., Merkle S., Cazorla O., Ouille A., Dupuis M., Hadri L., Jeong D., Muhlstedt S., Schmitt J., Braun A., Benard L., Saliba Y., Laggerbauer B., Nieswandt B., Lacampagne A., Hajjar R.J., Lompre A.M., Engelhardt S. Critical role for stromal interaction molecule 1 in cardiac hypertrophy. Circulation 2011, 124:796-805.
21. Funari V.A., Winkler M., Brown J., Dimitrijevich S.D., Ljubimov A.V., Saghizadeh M. Differentially expressed wound healing-related microRNAs in the human diabetic cornea. PLoS ONE 2013, 8:e84425.
22. Zhang J., Chang J.J., Xu F., Ma X.J., Wu Y., Li W.C., Wang H.J., Huang G.Y., Ma D. MicroRNA deregulation in right ventricular outflow tract myocardium in nonsyndromic tetralogy of fallot. Can. J. Cardiol. 2013, 29:1695-1703.
23. Yu W., Chen C., Fu Y., Wang X., Wang W. Insulin signaling: a possible pathogenesis of cardiac hypertrophy. Cardiovasc. Ther. 2010, 28:101-105.
24. Dorn G.W., Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. J. Clin. Invest. 2005, 115:527-537.
25. Zhu H., Shyh-Chang N., Segre A.V., Shinoda G., Shah S.P., Einhorn W.S., Takeuchi A., Engreitz J.M., Hagan J.P., Kharas M.G., Urbach A., Thornton J.E., Triboulet R., Gregory R.I., Altshuler D., Daley G.Q. The Lin28/let-axis regulates glucose metabolism. Cell 2011, 147:81-94.
26. Montaigne D., Marechal X., Coisne A., Debry N., Modine T., Fayad G., Potelle C., El Arid J.M., Mouton S., Sebti Y., Duez H., Preau S., Remy-Jouet I., Zerimech F., Koussa M., Richard V., Neviere R., Edme J.L., Lefebvre P., Staels B. Myocardial contractile dysfunction is associated with impaired mitochondrial function and dynamics in type 2 diabetic but not in obese patients. Circulation 2014, 130:554-564.
27. Buchanan J., Mazumder P.K., Hu P., Chakrabarti G., Roberts M.W., Yun U.J., Cooksey R.C., Litwin S.E., Abel E.D. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 2005, 146:5341-5349.
28. Mazumder P.K., O'Neill B.T., Roberts M.W., Buchanan J., Yun U.J., Cooksey R.C., Boudina S., Abel E.D. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes 2004, 53:2366-2374.